Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

347 ARTÍCULOS , VIENDO DEL 31 AL 45

3-(2,4-dimethoxybenzylidene)-anabaseine: a promising candidate drug for Alzheimer's disease?

Zawieja P, Kornprobst JM, Métais P.

Geriatr Gerontol Int. 2012 Jul;12(3):365-71. doi: 10.1111/j.1447-0594.2011.00827.x. Epub 2012 Feb 2.

Effects of Food and Drug Administration-approved medications for Alzheimer's disease on clinical progression

Mielke MM, Leoutsakos JM, Corcoran CD, Green RC, Norton MC, Welsh-Bohmer KA, Tschanz JT, Lyketsos CG.

Alzheimers Dement. 2012 May;8(3):180-7. doi: 10.1016/j.jalz.2011.02.011. Epub 2012 Feb 1.

Evaluation of the performance of novel Aβ isoforms as theragnostic markers in Alzheimer's disease: from the cell to the patient

Portelius E, Gustavsson MK, Zetterberg H, Andreasson U, Blennow K.

Neurodegener Dis. 2012;10(1-4):138-40. doi: 10.1159/000334537. Epub 2012 Feb 1.

A survey of peptides with effective therapeutic potential in Alzheimer's disease rodent models or in human clinical studies

Sun N, Funke SA, Willbold D.

Mini Rev Med Chem. 2012 May;12(5):388-98. doi: 10.2174/138955712800493942.

QSAR applications during last decade on inhibitors of acetylcholinesterase in Alzheimer's disease

Wong KY, Duchowicz PR, Mercader AG, Castro EA.

Mini Rev Med Chem. 2012 Sep 1;12(10):936-46. doi: 10.2174/138955712802762365.

Presenilins and γ-secretase: structure, function, and role in Alzheimer Disease

De Strooper B, Iwatsubo T, Wolfe MS.

Cold Spring Harb Perspect Med. 2012 Jan;2(1):a006304. doi: 10.1101/cshperspect.a006304.

Sirtuins in cognitive ageing and Alzheimer's disease

Braidy N, Jayasena T, Poljak A, Sachdev PS.

Curr Opin Psychiatry. 2012 May;25(3):226-30. doi: 10.1097/YCO.0b013e32835112c1.

Progressive and unconventional pharmacotherapeutic approaches to Alzheimer's disease therapy

Maudsley S, Chadwick W.

Curr Alzheimer Res. 2012 Jan;9(1):1-4. doi: 10.2174/156720512799015082.

Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease

de la Monte SM.

Curr Alzheimer Res. 2012 Jan;9(1):35-66. doi: 10.2174/156720512799015037.

Ethnobotanical treatment strategies against Alzheimer's disease

Howes MJ, Houghton PJ.

Curr Alzheimer Res. 2012 Jan;9(1):67-85. doi: 10.2174/156720512799015046.

Chronobiological approaches to Alzheimer's disease

Stranahan AM.

Curr Alzheimer Res. 2012 Jan;9(1):93-8. doi: 10.2174/156720512799015028.

Therapeutic targeting of the endoplasmic reticulum in Alzheimer's disease

Chadwick W, Mitchell N, Martin B, Maudsley S.

Curr Alzheimer Res. 2012 Jan;9(1):110-9. doi: 10.2174/156720512799015055.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias